Jie Mao
Sydney, NSW, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
The myeloid cell leukaemia-1 inhibitor MIK665 is a potent therapy in preclinical models of paediatric acute myeloid leukaemia.
Journal: British journal of haematology
Published: August 14, 2025
High-throughput 3D engineered paediatric tumour models for precision medicine.
Journal: Molecular systems biology
Published: August 13, 2025
Comprehensive Multiplatform Tyrosine Kinase Profiling Reveals Novel Actionable FGFR Aberrations across Sarcomas Affecting the Young.
Journal: Molecular cancer therapeutics
Published: July 01, 2025
Comprehensive multi-platform tyrosine kinase profiling reveals novel actionable FGFR aberrations across sarcomas affecting the young.
Journal: Molecular cancer therapeutics
Published: July 01, 2025
Modeling High-Risk Pediatric Cancers in Zebrafish to Inform Precision Therapy.
Journal: Cancer research communications
Published: February 07, 2025
A novel TRKB-activating internal tandem duplication characterizes a new mechanism of receptor tyrosine kinase activation.
Journal: NPJ precision oncology
Published: November 18, 2024
A novel MYB::PAIP1 oncogenic fusion in pediatric blastic plasmacytoid dendritic cell neoplasm (BPDCN) is dependent on BCL2 expression and is sensitive to venetoclax.
Journal: HemaSphere
Published: August 31, 2023
High-Throughput Drug Screening of Primary Tumor Cells Identifies Therapeutic Strategies for Treating Children with High-Risk Cancer.
Journal: Cancer research
Published: November 28, 2022
Showing 1-9 of 9
Last Updated: 09/26/2026